Program areas at MRA
The Melanoma Research Alliance Foundation ("mra") supports ambitious and innovative projects, selected through a peer-review panel and initiated by individual scientists and science Research teams, to prevent, detect and treat Melanoma. Mra convenes a world class, cross-disciplinary group of expert researchers possessing clinical and scientific expertise to develop a Research agenda that will provide innovative solutions to critical Research issues leading to more effective prevention, earlier detection and better treatments for Melanoma. Mra makes grants to domestic and foreign Research universities, medical schools, and nonprofit medical Research organizations directly involved in determining the causes and cures of Melanoma on the condition that such Research be made available to the scientific community.
The mra operates a patient engagement program that supports increased awareness of Melanoma in general, and of prevention, detection and treatment options specifically. The patient engagement program also provides education about and promotion of clinical trials. The patient engagement program includes development and distribution of educational materials, the provision of educational forums, a clinical trial navigator for patients and an on-line patient community.
Who funds Melanoma Research Alliance (MRA)
Grants from foundations and other nonprofits
Personnel at MRA
Name | Title | Compensation | Date of data |
---|
Marc Hurlbert | Chief Executive Officer | $365,698 | 2024-01-29 |
Michael Kaplan | President and Chief Executive Officer | $379,946 | 2022-12-31 |
Stephanie Kauffman | President and Chief Operating Officer | $187,636 | 2024-01-29 |
Joan Levy | Chief Science Officer | $182,089 | 2024-01-29 |
Cody Barnett | Senior Director of Communications and Patient Engagement | $123,825 | 2024-01-29 |
...and 10 more key personnel |
Financials for MRA
Revenues | FYE 12/2023 | FYE 12/2022 | % Change |
---|
Total grants, contributions, etc. | $8,539,530 | $11,591,019 | -26.3% |
Program services | $0 | $0 | - |
Investment income and dividends | $905,624 | $320,977 | 182.1% |
Tax-exempt bond proceeds | $0 | $0 | - |
Royalty revenue | $0 | $0 | - |
Net rental income | $0 | $0 | - |
Net gain from sale of non-inventory assets | $0 | $0 | - |
Net income from fundraising events | $-161,282 | $-297,357 | 45.8% |
Net income from gaming activities | $0 | $0 | - |
Net income from sales of inventory | $0 | $0 | - |
Miscellaneous revenues | $7,826 | $0 | 999% |
Total revenues | $9,291,698 | $11,614,639 | -20% |
Organizations like MRA
Organization | Type | Location | Revenue |
---|
Diabetes Research Institute Foundation (DRIF) | 501(c)(3) | Hollywood, FL | $7,129,662 |
Lymphoma Research Foundation (LRF) | 501(c)(3) | New York, NY | $16,566,956 |
H Lee Moffitt Cancer Center and Research Institute Foundation | 501(c)(3) | Tampa, FL | $34,168,930 |
Friedreichs Ataxia Research Alliance (FARA) | 501(c)(3) | Springfield, VA | $11,203,043 |
Cancer Research Institute (CRI) | 501(c)(3) | New York, NY | $32,295,259 |
National Foundation for Cancer Research (NFCR) | 501(c)(3) | Rockville, MD | $9,162,442 |
Israel Cancer Research Fund | 501(c)(3) | New York, NY | $7,728,171 |
Damon Runyon Cancer Research Foundation | 501(c)(3) | New York, NY | $15,715,675 |
Children's Cancer Research Fund | 501(c)(3) | Minneapolis, MN | $18,385,764 |
Fanconi Cancer Foundation | 501(c)(3) | Eugene, OR | $3,493,638 |
Data update history
January 6, 2025
Used new vendors
Identified 1 new vendor, including
January 5, 2025
Posted financials
Added Form 990 for fiscal year 2023
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsChapter / child organizationsCharities
Issues
HealthDiseases and disorders
Characteristics
Provides grantsConducts researchLobbyingFundraising eventsOperates internationallyNational levelTax deductible donationsAccepts online donations
General information
- Address
- 730 15th St NW 4th Floor
- Washington, DC 20005
- Metro area
- Washington-Arlington-Alexandria, DC-VA-MD-WV
- County
- District of Columbia, DC
- Website URL
- curemelanoma.org/Â
- Phone
- (202) 336-8935
- Facebook page
- MelanomaResearchAllianceÂ
- Twitter profile
- @melanomarealliÂ
IRS details
- EIN
- 26-1636099
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2007
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- H30: Cancer Research
- NAICS code, primary
- 813212: Health and Disease Research Fundraising Organizations
- Parent/child status
- Subordinate organization
California AB-488 details
- AB 488 status
- May Operate or Solicit for Charitable Purposes
- Charity Registration status
- Current - In Process
- FTB status revoked
- Not revoked
- AG Registration Number
- CT0147155
- FTB Entity ID
- 3152790
- AB 488 data last updated ("as-of") date
- 2025-02-19
Free account sign-up
Want updates when MRA has new information, or want to find more organizations like Melanoma Research Alliance (MRA)?
Create free Cause IQ account